Natural Compounds as Inhibitors of SARS-CoV-2 Main Protease (3CLpro): A Molecular Docking and Simulation Approach to Combat COVID-19
Journal:
Current Pharmaceutical Design
Volume:
27
Page:
3577-3589
Author(s):
Md. Tabish Rehman*, Mohamed F. AlAjmi and Afzal Hussain*
COVID-19: Epidemiology, Pathology, Diagnosis, Treatment, and Impact
Journal:
Current Pharmaceutical Design
Volume:
27
Page:
3502-3525
Author(s):
Saimon Shahriar, Md. Sohel Rana, Md. Sabbir Hossain, Ariful Karim, Tasneem N. Mredula, Nadia Nourin, Md. Sahab Uddin* and Md. Shah Amran*
COVID-19: An Update on Pathogenesis and Treatment
Journal:
Current Pharmaceutical Design
Volume:
27
Page:
3454-3461
Author(s):
Marwa A. AL Dhamen, Abrar F. Alhashim, Hawra H. Alqattan and Faheem H. Pottoo*
Natural Products: A Rich Source of Antiviral Drug Lead Candidates for the Management of COVID-19
Journal:
Current Pharmaceutical Design
Volume:
27
Page:
3526-3550
Author(s):
Yasanandana S. Wijayasinghe, Pravin Bhansali, Ronald E. Viola, Mohammad A. Kamal and Nitesh K. Poddar*
The Influence of Genetic Variations and Drug Interactions Based on Metabolism of Antidepressants and Anticonvulsants
Journal:
Current Drug Metabolism
Volume:
22
Page:
596-627
Author(s):
Merve D. Oz, Fezile Ozdemir and Halit S. Suzen*
CYP3A4 *1B Gene Polymorphism in Coronary Artery Disease Patients with Obesity Undergoing Statin Treatment
Journal:
Current Pharmacogenomics and Personalized Medicine
Volume:
18
Page:
18-23
Author(s):
Elifcan Gezer, Mehtap Cevik, Cansu Selcan Akdeniz, Ismail Polat Canbolat, Selen Yurdakul, Murat Sunbul, Penbe Cagatay, Gokce Deliorman, Atila Karaalp, Cavlan Ciftci and Belgin Susleyici*
Effects on the Post-translational Modification of H3K4Me3, H3K9ac, H3K9Me2, H3K27Me3, and H3K36Me2 Levels in Cerebral Cortex, Hypothalamus and Pons of Rats after a Systemic Administration of Cannabidiol: A Preliminary Study
Journal:
Central Nervous System Agents in Medicinal Chemistry
Volume:
21
Page:
142-147
Author(s):
José Carlos Pastrana-Trejo, Fátima Duarte-Aké, Rosa Us-Camas, Clelia De-la-Peña, Linda Parker, Roger G. Pertwee and Eric Murillo-Rodríguez*
Outcomes in Pregnant Patients with Subclinical Hypothyroidism and Thyroid Autoimmunity: A Critical Appraisal of Recent Randomized Controlled Trials
Journal:
Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume:
21
Page:
1387-1391
Author(s):
Roberto Negro*
Maternal Sodium Valproate Exposure Alters Neuroendocrine-Cytokines and Oxido-inflammatory Axes in Neonatal Albino Rats
Journal:
Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume:
21
Page:
1491-1503
Author(s):
Neama A-G, El-bakry AM, Rasha EH and RG Ahmed*
An Overview of Targeting Legumain for Inhibiting Cancers
Journal:
Current Pharmaceutical Design
Volume:
27
Page:
3337-3348
Author(s):
Bandi D. Reddy, Narasimha M. Beeraka, CH. M. Kumari Chitturi and SubbaRao V. Madhunapantula*